NCT06883474

Brief Summary

The study specifically investigated PC patients with bone metastasis and conducted a comprehensive analysis of the correlation between OCs and patient survival outcomes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
211

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2010

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
12.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

March 13, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 19, 2025

Completed
Last Updated

March 21, 2025

Status Verified

October 1, 2024

Enrollment Period

12.9 years

First QC Date

March 13, 2025

Last Update Submit

March 18, 2025

Conditions

Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease

Keywords

Bone metastasiscomputed tomographyosteosclerotic changeprostate cancer

Outcome Measures

Primary Outcomes (1)

  • Radiographic progression-free survival

    From enrollment to the end of treatment at 5 years

Secondary Outcomes (1)

  • overall survival

    From enrollment to the end of treatment at 5 years

Interventions

Osteosclerotic Changes on Computed TomographyOTHER

Osteosclerotic Changes on Computed Tomography

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Prostate cancer patients with bone metastasis

You may qualify if:

  • ）Histopathological confirmation of prostate adenocarcinoma
  • ）Radiologically verified bone metastasis, assessed through bone scintigraphy and CT imaging from the initiation of systemic therapy until disease progression.

You may not qualify if:

  • ）Lacking of complete clinical profiles.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Prostatic NeoplasmsAdenocarcinoma

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

March 13, 2025

First Posted

March 19, 2025

Study Start

July 1, 2010

Primary Completion

May 30, 2023

Study Completion

May 30, 2023

Last Updated

March 21, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share